{"id":48953,"date":"2022-09-29T10:03:15","date_gmt":"2022-09-29T08:03:15","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/"},"modified":"2022-09-29T10:03:15","modified_gmt":"2022-09-29T08:03:15","slug":"ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/","title":{"rendered":"Ultivue and ngTMA\u00ae Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research"},"content":{"rendered":"
\n

CAMBRIDGE, Mass. & BERN, Switzerland–(BUSINESS WIRE)–Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies and, the Translational Research Unit (TRU) platform of University of Bern, that develops novel workflows for tissue microarray (ngTMA\u00ae<\/sup>) construction, announce a collaborative agreement to promote multiplexed immunofluorescence (mIF) assays and the use of next generation TMAs to unlock spatial analysis in scientific research and improve the quality of TMAs integrated in clinical and translational research.\n<\/p>\n

<\/a><\/p>\n

\nUltivue develops unique solutions for use in mIF applications, imaging, and spatial phenomics. Its proprietary InSituPlex\u00ae<\/sup> technology enabling improved signal to noise data is designed for fast and comprehensive exploration of biologically relevant targets, up to 12-plex, with same slide-H&E analysis in tissue samples combines the power of computational pathology & spatial biology to guide translational science in immuno-oncology.\n<\/p>\n

\nngTMA\u00ae<\/sup> supports research collaborators with an interdisciplinary approach to studying tumor biology and disease states. Services include scientific consulting and TMA design, digital slide annotation, automated tissue punching and documentation for quality control. The ngTMA\u00ae<\/sup> platform is embedded in an innovative research framework and as part of the Translational Research Unit (TRU), Institute of Pathology, University of Bern, with expertise in tissue-related technologies.\n<\/p>\n

\n\u201cWe are thrilled to be partnering with ngTMA\u00ae<\/sup> to jointly empower biopharma customers with tissue multiplex services. In addition, our scientific collaboration will investigate the relevance of the tumor microenvironment by characterizing clinically well-annotated cohorts using Ultivue reagents at ngTMA,\u201d said Florian Leiss, Ph.D. Vice President Product Strategy & Corporate Development at Ultivue.\n<\/p>\n

\n\u201cWe are very excited to join forces with the Ultivue team and have their reagents in our pipeline in order to support translational research of our collaborators,\u201d Said Paulina Br\u00f6nnimann, PhD, Head of Translational Research Unit.\n<\/p>\n

\nAbout the Translational Research Unit and ngTMA<\/b>\u00ae<\/sup>\n<\/p>\n

\nTRU is a core facility at the Institute of Pathology at the University of Bern, providing human and animal tissue-related services with expertise in histology, tissue visualization, digital pathology, image analysis and construction of next-generation Tissue Microarrays (learn more at https:\/\/www.ngtma.com\/<\/a>).\n<\/p>\n

\nAbout Ultivue<\/b>\n<\/p>\n

\nUltivue provides researchers and scientists in translational medicine with multiplex biomarker assays for tissue phenotyping and digital pathology. Its proprietary InSituPlex\u00ae<\/sup> technology enables advanced exploration and interrogation of tissue samples for precision medicine research. These highly customizable solutions coupled with our scientific consultative approach strengthen and accelerate biomarker discovery and drug development programs. Learn more at Ultivue.com.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nngTMA<\/b>
Paulina Br\u00f6nnimann PhD
\n
Head of Translational Research Unit
\n
paulina.broennimann@unibe.ch<\/a>\n<\/p>\n

\nUltivue<\/b>
Florian Leiss PhD
\n
Vice President Product Strategy & Corporate Development
\n
Florian.leiss@ultivue.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass. & BERN, Switzerland–(BUSINESS WIRE)–Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies and, the Translational Research Unit (TRU) platform of University of Bern, that develops novel workflows for tissue microarray (ngTMA\u00ae) construction, announce a collaborative agreement to promote multiplexed immunofluorescence (mIF) assays and the use … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-48953","format-standard","category-industry"],"yoast_head":"\nUltivue and ngTMA\u00ae Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ultivue and ngTMA\u00ae Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass. & BERN, Switzerland–(BUSINESS WIRE)–Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies and, the Translational Research Unit (TRU) platform of University of Bern, that develops novel workflows for tissue microarray (ngTMA\u00ae) construction, announce a collaborative agreement to promote multiplexed immunofluorescence (mIF) assays and the use ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-29T08:03:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220929005039\/en\/1585398\/21\/logo_Ultivue_black_large.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Ultivue and ngTMA\u00ae Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research\",\"datePublished\":\"2022-09-29T08:03:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/\"},\"wordCount\":451,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220929005039\\\/en\\\/1585398\\\/21\\\/logo_Ultivue_black_large.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/\",\"name\":\"Ultivue and ngTMA\u00ae Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220929005039\\\/en\\\/1585398\\\/21\\\/logo_Ultivue_black_large.jpg\",\"datePublished\":\"2022-09-29T08:03:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220929005039\\\/en\\\/1585398\\\/21\\\/logo_Ultivue_black_large.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220929005039\\\/en\\\/1585398\\\/21\\\/logo_Ultivue_black_large.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ultivue and ngTMA\u00ae Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ultivue and ngTMA\u00ae Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/","og_locale":"en_US","og_type":"article","og_title":"Ultivue and ngTMA\u00ae Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research - Pharma Trend","og_description":"CAMBRIDGE, Mass. & BERN, Switzerland–(BUSINESS WIRE)–Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies and, the Translational Research Unit (TRU) platform of University of Bern, that develops novel workflows for tissue microarray (ngTMA\u00ae) construction, announce a collaborative agreement to promote multiplexed immunofluorescence (mIF) assays and the use ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-29T08:03:15+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220929005039\/en\/1585398\/21\/logo_Ultivue_black_large.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Ultivue and ngTMA\u00ae Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research","datePublished":"2022-09-29T08:03:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/"},"wordCount":451,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220929005039\/en\/1585398\/21\/logo_Ultivue_black_large.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/","url":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/","name":"Ultivue and ngTMA\u00ae Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220929005039\/en\/1585398\/21\/logo_Ultivue_black_large.jpg","datePublished":"2022-09-29T08:03:15+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220929005039\/en\/1585398\/21\/logo_Ultivue_black_large.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220929005039\/en\/1585398\/21\/logo_Ultivue_black_large.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ultivue-and-ngtma-announce-collaborative-agreement-to-provide-multiplex-and-spatial-analysis-for-clinical-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ultivue and ngTMA\u00ae Announce Collaborative Agreement to Provide Multiplex and Spatial Analysis for Clinical Research"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48953"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48953\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}